دورية أكاديمية

Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
المؤلفون: Tan, Antoinette R *, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Yang, Zhao, Antal, Joyce M, Morris, Shannon R, O'Shaughnessy, Joyce
المصدر: In The Lancet Oncology November 2019 20(11):1587-1601
قاعدة البيانات: ScienceDirect
الوصف
تدمد:14702045
DOI:10.1016/S1470-2045(19)30616-3